Forecast & Rating2 analysts currently cover BIOCYTOGEN-B, of which 2 give a positive rating. The average price target is HK$62.03, about 7.1% upside from the current price of HK$57.90. Coverage is limited, so the data is for reference only. Data as of Jul 6, 2026; this does not constitute investment advice.
Jul 4, 2026Price forecast
HK$62.037.14%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 6, 2026
Forecast met53.8%
Stock price$57.90
Avg. target$62.0
High target$62
Low target$62
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.